From Our Affiliates

Tag: BioMarin

A total of 15 posts are filed under BioMarin
Exclusivity: How The Government Keeps Orphan Drugs in Production
Why did the FDA grant BioMarin this permission, known in bureaucratic lingo as a “six-month pediatric exclusivity extension?”… Continue Reading
BioMarin Gets U.S. Panel’s Backing on Rare Disease Drug
BioMarin Pharmaceutical Inc. received the backing of U.S. advisers for a drug to treat a rare metabolic disease that can affect growth. The… Continue Reading
Roche CEO Severin Schwan
Is Roche Going to Do Some Big Rare Disease Drug Deals?
So is Roche going to do some rare disease deals or not? Rumors of a possible buyout of Alexion and BioMarin– alternatively dissed… Continue Reading
Startup Ultragenyx Snags PiII Program for Growing Rare-Disease Pipeline
Flush from raising more than $100 million, Novato, CA-based startup Ultragenyx Pharmaceutical has stepped up with a new pact to partner on… Continue Reading
Nimbus Discovery, Shire to Co-Develop Oral Rare Disease Drugs
Nimbus Discovery splashed onto the scene in 2011 with a big-name investor group that included Bill Gates and a plan to discover drugs with… Continue Reading
Chris Mann, Nestor Serrano, Jason George and Katrina Parker
Faircraft Records/Universal Republic Recording artist Chris Mann and Singer/Songwriter Katrina Parker to Perform at Global Genes | R.A.R.E Project’s Tribute to Champions of Hope™ Benefit
FOR IMMEDIATE RELEASE Actors Jason George, Nestor Serrano and Meagan Tandy will Serve as Celebrity Award Presenters; Henri Termeer, Former… Continue Reading
Global Genes and R.A.R.E. Project Announce Tribute to Champions of Hope™ Gala to Honor Rare and Genetic Disease Pioneers, Innovators and Advocates
Henri Termeer, Biotech Legend and former President and CEO of Genzyme, To Receive Lifetime Achievement Award; Nominations Now Being Accepted… Continue Reading

Follow us on Twitter